Alexander V Lazarev - 14 Sep 2021 Form 4 Insider Report for PRESSURE BIOSCIENCES INC

Role
VP of Research & Development
Signature
/s/ Alexander Lazarev
Issuer symbol
N/A
Transactions as of
14 Sep 2021
Net transactions value
+$66,250
Form type
4
Filing time
16 Sep 2021, 21:51:13 UTC
Next filing
03 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBIO SERIES AA CONVERTIBLE PREFERRED STOCK Purchase $66,250 +26 $2500.00* 26 14 Sep 2021 COMMON STOCK 26,460 $2.50 Direct F1, F3
transaction PBIO COMMON STOCK WARRANT Purchase +26,460 26,460 14 Sep 2021 COMMON STOCK 26,460 $3.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series AA Convertible Preferred Stock converts into 1,000 shares of the Company's Common Stock at a conversion price of $2.50 per share.
F2 Each Warrant gives the investor the right to purchase the number of shares of Common Stock equal to 100% of the number of shares of Common Stock issuable upon conversion of the total number of Series AA Convertible Preferred Stock units purchased, at an exercise price of $3.50 per share.
F3 No expiration date for the Series AA preferred stock.